Cargando…
Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options
As with any health threat, our ability to respond to the emergence and spread of antimicrobial resistance depends on our ability to understand the scale of the problem, magnitude, geographical spread, and trends over time. This is especially true for resistance emergence to newer antibiotics coming...
Autores principales: | Morel, Chantal M., de Kraker, Marlieke E. A., Harbarth, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091962/ https://www.ncbi.nlm.nih.gov/pubmed/33954161 http://dx.doi.org/10.3389/fmed.2021.652638 |
Ejemplares similares
-
Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus
por: Morel, Chantal M., et al.
Publicado: (2020) -
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
por: de Kraker, Marlieke E. A., et al.
Publicado: (2016) -
Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria
por: Pezzani, Maria Diletta, et al.
Publicado: (2021) -
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE’s STAT-Net
por: Timsit, Jean-François, et al.
Publicado: (2017) -
Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?
por: Edwards, Suzanne E., et al.
Publicado: (2018)